Skip to main content
HIGH TECH PHARM CO.,LTD. logo

HIGH TECH PHARM CO.,LTD. — Investor Relations & Filings

Ticker · 106190 ISIN · KR7106190002 KO Manufacturing
Open in API
Filings indexed 169 across all filing types
Latest filing 2026-02-23 Proxy Solicitation & In…
Country KR South Korea
Listing KO 106190

About HIGH TECH PHARM CO.,LTD.

http://www.htpharm.com/eng/

HIGH TECH PHARM CO.,LTD. is a pharmaceutical company specializing in the development and manufacturing of active pharmaceutical ingredients (APIs), with a primary focus on sterile, carbapenem-based antibiotic raw materials. Established in 1998, the company has gained global recognition for its advanced technology and high-quality products, which are supplied to over 40 countries. A significant majority of its sales are generated from exports to demanding overseas markets, including Europe. The company operates state-of-the-art manufacturing facilities, such as its Chungju plant, designed to meet the rigorous standards of advanced regulatory authorities like the U.S. FDA and European EDQM. Through a commitment to a quality-first policy and continuous research and development, HIGH TECH PHARM aims to solidify its position as a leading global supplier of antibiotic drug substances.

Recent filings

Filing Released Lang Actions
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal notice of an Annual General Meeting (AGM) for the company 'Hitech Pharm'. It details the meeting date, location, agenda items (such as financial statement approval, director appointments, and governance changes), and provides specific details on board and auditor nominations. This document is a standard proxy solicitation and meeting notice provided to shareholders to inform them of the upcoming meeting and request their participation/votes. Therefore, it falls under the Proxy Solicitation & Information Statement category.
2026-02-23 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Hitech Pharm regarding a decision on cash dividends. It specifies the dividend amount per share, the record date, the payment date, and the approval process by the board of directors. This content directly matches the definition for a 'Notice of Dividend Amount' (DIV).
2026-02-05 Korean
현금ㆍ현물배당을위한주주명부폐쇄(기준일)결정
Notice of Dividend Amount Classification · 98% confidence The document is a regulatory announcement from Hitech Pharm regarding the setting of a record date for shareholder registry closure for the purpose of future cash/in-kind dividends. It explicitly states that this is not the final dividend declaration, but a procedural step to determine eligible shareholders for future dividends. Since it relates to dividend procedures and shareholder rights, it falls under the category of regulatory announcements regarding corporate actions.
2025-12-16 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 95% confidence The document is a formal notice regarding the setting of a record date for the purpose of holding an Annual General Meeting (AGM). It specifies the record date (2025-12-31) and the purpose (convening the 28th Annual General Meeting). Since this is a regulatory announcement regarding the preparation for an AGM rather than the AGM presentation materials themselves, and it does not fit into other specific categories like dividend or share issuance, it is classified as a general regulatory filing.
2025-12-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 91% confidence The document is a Korean regulatory filing titled “임원ㆍ주요주주 특정증권등 소유상황보고서,” detailing changes in an officer’s share ownership (dates, share counts, purchase methods). This matches an insider transaction report by directors/executives. Therefore, it falls under Director’s Dealing (DIRS).
2025-09-22 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 92% confidence The document is a ‘주식등의 대량보유상황보고서’ – a large shareholding status report filed under Korea’s Capital Markets Act. It details the number and percentage of shares held by ACS DOBFAR S.P.A and related parties, describes changes in ownership thresholds, and is a direct notification of significant share ownership. This aligns precisely with the “Major Shareholding Notification” category.
2025-09-22 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.